메뉴 건너뛰기




Volumn 174, Issue 2, 2005, Pages 668-672

Results of compliance with prostate cancer screening guidelines

Author keywords

Diagnosis; Guideline adherence; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 22144445994     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000165149.66186.23     Document Type: Article
Times cited : (7)

References (18)
  • 1
    • 8444251062 scopus 로고    scopus 로고
    • Prostate-specific antigen (PSA) best practice policy
    • American Urological Association (AUA)
    • Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology, 14: 267, 2000
    • (2000) Oncology , vol.14 , pp. 267
  • 2
    • 1542288225 scopus 로고    scopus 로고
    • American Cancer Society guidelines for the early detection of cancer, 2004
    • Smith, R. A., Cokkinides, V., Eyre, H. J. and American Cancer Society: American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin, 54: 41, 2004
    • (2004) CA Cancer J Clin , vol.54 , pp. 41
    • Smith, R.A.1    Cokkinides, V.2    Eyre, H.J.3
  • 4
    • 0031055722 scopus 로고    scopus 로고
    • Screening for prostate cancer
    • American College of Physicians
    • Screening for prostate cancer. American College of Physicians. Ann Intern Med, 126: 480, 1997
    • (1997) Ann Intern Med , vol.126 , pp. 480
  • 5
    • 23944441801 scopus 로고    scopus 로고
    • Rockville, Maryland: Agency for Healthcare Research and Quality
    • U.S. Preventive Services Task Force: Screening for Prostate Cancer: Recommendations and Rationale. Rockville, Maryland: Agency for Healthcare Research and Quality, 2002. Available at http://www.ahrq.gov/clinic/3rduspstf/ prostatescr/prostaterr.htm. Accessed September 10, 2004
    • (2002) Screening for Prostate Cancer: Recommendations and Rationale
  • 6
    • 0030693736 scopus 로고    scopus 로고
    • The early detection of prostate carcinoma with prostate specific antigen: The Washington University experience
    • Smith, D. S., Humphrey, P. A. and Catalona, W. J.: The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Cancer, 80: 1852, 1997
    • (1997) Cancer , vol.80 , pp. 1852
    • Smith, D.S.1    Humphrey, P.A.2    Catalona, W.J.3
  • 7
    • 0024393833 scopus 로고
    • Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate
    • Hodge, K. K., McNeal, J. E., Terris, M. K. and Stamey, T. A.: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol, 142: 71, 1989
    • (1989) J Urol , vol.142 , pp. 71
    • Hodge, K.K.1    McNeal, J.E.2    Terris, M.K.3    Stamey, T.A.4
  • 8
    • 0025849053 scopus 로고
    • Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
    • Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 324: 1156, 1991
    • (1991) N Engl J Med , vol.324 , pp. 1156
    • Catalona, W.J.1    Smith, D.S.2    Ratliff, T.L.3    Dodds, K.M.4    Coplen, D.E.5    Yuan, J.J.6
  • 10
    • 0030989397 scopus 로고    scopus 로고
    • Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues
    • Humphrey, P. A. and Vollmer, R. T.: Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol, 10: 326, 1997
    • (1997) Mod Pathol , vol.10 , pp. 326
    • Humphrey, P.A.1    Vollmer, R.T.2
  • 11
    • 0015950349 scopus 로고
    • Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
    • Gleason, D. F. and Mellinger, G. T.: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 111: 58, 1974
    • (1974) J Urol , vol.111 , pp. 58
    • Gleason, D.F.1    Mellinger, G.T.2
  • 12
    • 0032823983 scopus 로고    scopus 로고
    • Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
    • Epstein, J. I., Chan, D. W., Sokoll, L. J., Walsh, P. C., Cox, J. L., Rittenhouse, H. et al: Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol, 160: 2407, 1998
    • (1998) J Urol , vol.160 , pp. 2407
    • Epstein, J.I.1    Chan, D.W.2    Sokoll, L.J.3    Walsh, P.C.4    Cox, J.L.5    Rittenhouse, H.6
  • 13
    • 0031309552 scopus 로고    scopus 로고
    • Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer
    • Hoedemaeker, R. F., Rietbergen, J. B., Kranse, R., van der Kwast, T. H. and Schroder, F. H.: Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer. World J Urol, 15: 339, 1997
    • (1997) World J Urol , vol.15 , pp. 339
    • Hoedemaeker, R.F.1    Rietbergen, J.B.2    Kranse, R.3    Van Der Kwast, T.H.4    Schroder, F.H.5
  • 14
    • 0032820899 scopus 로고    scopus 로고
    • Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results
    • Catalona, W. J. and Smith, D.S.: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol, 160: 2428, 1998
    • (1998) J Urol , vol.160 , pp. 2428
    • Catalona, W.J.1    Smith, D.S.2
  • 15
    • 0036141891 scopus 로고    scopus 로고
    • Cancer control with radical prostatectomy alone in 1,000 consecutive patients
    • Hull, G. W., Rabbani, F., Abbas, F., Wheeler, T. M., Kattan, M. W. and Scardino, P. T.: Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol, 167: 528, 2002
    • (2002) J Urol , vol.167 , pp. 528
    • Hull, G.W.1    Rabbani, F.2    Abbas, F.3    Wheeler, T.M.4    Kattan, M.W.5    Scardino, P.T.6
  • 16
    • 0036754570 scopus 로고    scopus 로고
    • Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features
    • Krumholtz, J. S., Carvalhal, G. F., Ramos, C. G., Smith, D. S., Thorson, P., Yan, Y. et al: Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features. Urology, 60: 469, 2002
    • (2002) Urology , vol.60 , pp. 469
    • Krumholtz, J.S.1    Carvalhal, G.F.2    Ramos, C.G.3    Smith, D.S.4    Thorson, P.5    Yan, Y.6
  • 17
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • D'Amico, A. V., Chen, M. H., Roehl, K. A. and Catalona, W. J.: Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med, 351: 125, 2004
    • (2004) N Engl J Med , vol.351 , pp. 125
    • D'Amico, A.V.1    Chen, M.H.2    Roehl, K.A.3    Catalona, W.J.4
  • 18
    • 84942475860 scopus 로고
    • Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
    • Epstein, J. I., Walsh, P. C., Carmichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA, 271: 368, 1994
    • (1994) JAMA , vol.271 , pp. 368
    • Epstein, J.I.1    Walsh, P.C.2    Carmichael, M.3    Brendler, C.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.